Pharmacotherapy of chronic spontaneous urticariaMAKRIS, Michael; MAURER, Marcus; ZUBERBIER, Torsten et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 18, pp 2511-2519, issn 1465-6566, 9 p.Article

Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitisNAGAKURA, T; OGINO, S; OKUBO, K et al.Clinical and experimental allergy (Print). 2008, Vol 38, Num 2, pp 329-337, issn 0954-7894, 9 p.Article

Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro modelHSU, Chuan-Long; SHIUNG, Yu-Yu; UN, Bai-Ling et al.International immunopharmacology (Print). 2010, Vol 10, Num 4, pp 533-539, issn 1567-5769, 7 p.Article

Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulusLOURENCO, F. D; AZOR, M. H; SANTOS, J. C et al.British journal of dermatology (1951). 2008, Vol 158, Num 5, pp 979-986, issn 0007-0963, 8 p.Article

Intérêt d'un traitement par omalizumab dans le cadre d'une immunothérapie spécifique. Recueil d'expérience et analyse de la littérature = The interest of treatment with omalizumab in the framework of specific immunotherapyOSTER, J.-P; LAVAUD, F; BENTALEB, A et al.Revue française d'allergologie (Amsterdam. Print). 2014, Vol 54, Num 5, pp 347-355, issn 1877-0312, 9 p.Article

The pharmacological mechanisms of omalizumab in patients with very high IgE levels—Clues from studies on atopic dermatitisTSE WEN CHANG; CHEN, Jiun-Bo; CHU, Chia-Yu et al.Zhōnghuá pífūkē yīxué zázhì. 2012, Vol 30, Num 4, pp 147-153, issn 1027-8117, 7 p.Article

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City ChildrenBUSSE, William W; MORGAN, WayneJ; CHMIEL, James F et al.The New England journal of medicine. 2011, Vol 364, Num 11, pp 1005-1015, issn 0028-4793, 11 p.Article

Low-affinity IgE receptor (FcεRII)-mediated activation of human monocytes by both monomeric IgE and IgE/anti-IgE immune complexEZEAMUZIE, Charles I; AL-ATTIYAH, Raja'a; SHIHAB, Puthiyaveetil K et al.International immunopharmacology (Print). 2009, Vol 9, Num 9, pp 1110-1114, issn 1567-5769, 5 p.Article

Non-psoriatic dermatologic uses of monoclonal antibody therapySOCKOLOV, Mary E; ALIKHAN, Ali; ZARGARI, Omid et al.Journal of dermatological treatment. 2009, Vol 20, Num 6, pp 319-327, issn 0954-6634, 9 p.Article

A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitisPINTO, J. M; MEHTA, N; DETINEO, M et al.Rhinology. 2010, Vol 48, Num 3, pp 318-324, issn 0300-0729, 7 p.Article

Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An updateD'AMATO, G; PERTICONE, M; BUCCHIONI, E et al.European annals of allergy and clinical immunology. 2010, Vol 42, Num 4, pp 135-140, issn 1764-1489, 6 p.Article

IDENTIFICATION OF BASOPHILIC GRANULOCYTES IN HUMAN LEUKOCYTE SUSPENSIONS SUBJECTED TO IMMUNOFLUORESCENCE PROCEDURES WITH ANTI-IGESTALLMAN PJ; FELTKAMP VROOM TM.1976; J. IMMUNOL. METHODS; NETHERL.; DA. 1976; VOL. 10; NO 2-3; PP. 271-277; BIBL. 18 REF.Article

Beneficial Effects of Treatment With Anti-IgE Antibodies (Omalizumab) in a Patient With Severe Asthma and Negative Skin-Prick Test ResultsVAN DEN BERGE, Maarten; PAUW, Ronald G; DE MONCHY, G. R et al.Chest (American College of Chest Physicians). 2011, Vol 139, Num 1, pp 190-193, issn 0012-3692, 4 p.Article

L'anti-IgE thérapie dans l'asthme = Ant-IgE treatment in asthmaMEHIRI BEN RHOUMA, Nadia; BEJI, Majed; LOUZIR, Béchir et al.Tunisie médicale. 2002, Vol 80, Num 10, pp 575-580, issn 0041-4131, 6 p.Article

Les anti-IgE et les traitements du futur des allergies respiratoires = Anti-IgE and future treatments for respiratory allergiesTUNON-DE-LARA, J.-M; RAHERISON, C; BERGER, P et al.Revue de pneumologie clinique (Paris). 2003, Vol 59, Num 2, pp 114-120, issn 0761-8417, 7 p., CAH2Conference Paper

Enhancement of basophil histamine release by a human basophil-like cell promoting activityMORITA, Y; HIRAI, K; MISAKI, Y et al.Allergy (Copenhagen). 1990, Vol 45, Num 3, pp 183-188, issn 0105-4538Article

Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008LIN, Robert Y; RODRIGUEZ-BAEZ, Gerson; BHARGAVE, Geeta A et al.Annals of allergy, asthma, & immunology. 2009, Vol 103, Num 5, pp 442-445, issn 1081-1206, 4 p.Article

Immunotherapy: 1999-2004NORMAN, Philip S.Journal of allergy and clinical immunology. 2004, Vol 113, Num 6, pp 1013-1023, issn 0091-6749, 11 p.Article

RESPONSE OF THE HUMAN NASAL MUCOUS MEMBRANE TO ANTI-HUMAN IGE SERUMOKUDA M.1975; ARCH. OTO-RHINO-LARYNGOL.; GERM.; DA. 1975; VOL. 211; NO 1; PP. 25-33; ABS. ALLEM; BIBL. 25 REF.Article

HUMAN ANTIBODIES WITH SPECIFICITY FOR THE PEPSIN SITE OF IGEMELLBYE OJ; WILLIAMS RC JR.1973; SCAND. J. IMMUNOL.,; NORWAY; DA. 1973; VOL. 2; NO 1; PP. 17-21; BIBL. 14REF.Serial Issue

Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapyCORREN, Jonathan; SHAPIRO, Gail; REIMANN, James et al.Journal of allergy and clinical immunology. 2008, Vol 121, Num 2, pp 506-511, issn 0091-6749, 6 p.Article

Traitement par anti-lgE d'un patient asthmatique, dialysé et greffé = Treatment of an asthmatic patient on dialysis and awaiting transplantation with anti-lgELAFOURCADE, M.-P; MARTIN, M; YVER, L et al.Revue des maladies respiratoires. 2008, Vol 25, Num 7, pp 857-860, issn 0761-8425, 4 p.Article

Future therapies for food allergies : Food allergyNOWAK-WEGRZYN, Anna; SAMPSON, Hugh A.Journal of allergy and clinical immunology. 2011, Vol 127, Num 3, pp 558-573, issn 0091-6749, 16 p.Article

Intérêt des immunoglobulines E sputaires: un biomarqueur de l'asthme indépendant de l'atopie ? : Asthme = Interest of sputum immunoglobulin E: a biomarker of asthma independent of atopy?MOUTHUY, J; PILETTE, C.La Lettre du pneumologue. 2014, Vol 17, Num 6, pp 206-208, issn 1292-5977, 3 p.Article

Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factorsMACGLASHAN, Donald W; SAVAGE, Jessica H; WOOD, Robert A et al.Journal of allergy and clinical immunology. 2012, Vol 130, Num 5, pp 1130-1135, issn 0091-6749, 6 p.Article